To further evaluate whether the reduced tumor growth and increased T cell density observed in GPR182−/− mice were dependent on the CXCR3 pathway, we treated mice with a CXCR3 blocking mAb throughout YUMM1.7 tumor inoculation. The gene discussed is CXCR3; the disease is neoplasm.